Insider trades › Randall Moreadith
Randall Moreadith
A corporate insider: an officer, director or owner of more than 10% of a company. Insiders report their trades to the SEC on Form 4The form insiders use to report each purchase or sale of their company's stock. It is due within two business days of the trade. · Last filing May 26, 2026
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, list Randall Moreadith's open-market buys and sells across companies in the last two years, with the Form 4 links.
Using 13F.ai, how did the stocks Randall Moreadith bought perform after the purchase compared with the S&P 500?
Using 13F.ai, are other insiders at the same companies buying or selling at the same time as Randall Moreadith?
Connect your AI · Plans and the 7-day free trial (card required)
Buying and selling by quarter
Dollars bought and sold on the open market over the last two years.
Bought Sold
By trade date, using the shares and price reported for each trade. Stock grants, option exercises and shares withheld for tax are left out.
Roles
The companies where this person reports as an insider, and their position at each, most recent first.
| Company | Role | Last filed |
|---|---|---|
| SER Serina Therapeutics, Inc. | Chief Scientific Officer | May 26, 2026 |
Roles come from the filings themselves and can change over time.
Latest open-market trades
Purchases and sales at every company, most recent filing first.
| How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss. | Filing | ||||||
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $2.86 | $18.6K | -71.0% | Form 4 ↗ |
| Mar 19, 2026 | SER Serina Therapeutics, Inc. | Sale | 39,000 | $2.50 | $97.5K | -58.3% | Form 4 ↗ |
| Feb 2, 2026 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $3.03 | $19.7K | -57.4% | Form 4 ↗ |
| Jan 28, 2026 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $3.57 | $23.2K | -57.4% | Form 4 ↗ |
| Jan 22, 2026 | SER Serina Therapeutics, Inc. | Sale | 2,500 | $2.95 | $7,375 | -62.5% | Form 4 ↗ |
| Jan 21, 2026 | SER Serina Therapeutics, Inc. | Sale | 2,000 | $3.00 | $6,000 | -61.3% | Form 4 ↗ |
| Jan 20, 2026 | SER Serina Therapeutics, Inc. | Sale | 2,000 | $3.07 | $6,140 | -62.9% | Form 4 ↗ |
| Jan 14, 2026 | SER Serina Therapeutics, Inc. | Sale | 1,084 | $2.50 | $2,710 | -57.2% | Form 4 ↗ |
| Jan 13, 2026 | SER Serina Therapeutics, Inc. | Sale | 5,416 | $2.50 | $13.5K | -52.2% | Form 4 ↗ |
| Jan 8, 2026 | SER Serina Therapeutics, Inc. | Sale | 13,000 | $2.69 | $35.0K | -56.4% | Form 4 ↗ |
| Dec 23, 2025 | SER Serina Therapeutics, Inc. | Sale | 4,100 | $2.60 | $10.7K | -54.5% | Form 4 ↗ |
| Dec 22, 2025 | SER Serina Therapeutics, Inc. | Sale | 5,673 | $2.67 | $15.1K | -57.7% | Form 4 ↗ |
| Dec 16, 2025 | SER Serina Therapeutics, Inc. | Sale | 3,227 | $2.96 | $9,552 | -63.5% | Form 4 ↗ |
| Dec 12, 2025 | SER Serina Therapeutics, Inc. | Sale | 1,700 | $3.26 | $5,542 | -66.1% | Form 4 ↗ |
| Dec 11, 2025 | SER Serina Therapeutics, Inc. | Sale | 3,555 | $3.24 | $11.5K | -65.2% | Form 4 ↗ |
| Dec 10, 2025 | SER Serina Therapeutics, Inc. | Sale | 645 | $3.35 | $2,161 | -66.4% | Form 4 ↗ |
| Dec 9, 2025 | SER Serina Therapeutics, Inc. | Sale | 600 | $3.31 | $1,986 | -68.4% | Form 4 ↗ |
| Dec 3, 2025 | SER Serina Therapeutics, Inc. | Sale | 5,000 | $3.52 | $17.6K | -70.4% | Form 4 ↗ |
| Dec 2, 2025 | SER Serina Therapeutics, Inc. | Sale | 1,500 | $3.91 | $5,865 | -74.2% | Form 4 ↗ |
| Nov 25, 2025 | SER Serina Therapeutics, Inc. | Sale | 5,965 | $3.90 | $23.3K | -76.2% | Form 4 ↗ |
| Nov 24, 2025 | SER Serina Therapeutics, Inc. | Sale | 535 | $3.94 | $2,108 | -75.7% | Form 4 ↗ |
| Nov 18, 2025 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $3.75 | $24.4K | -77.3% | Form 4 ↗ |
| Nov 10, 2025 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $4.10 | $26.6K | -75.9% | Form 4 ↗ |
| Nov 5, 2025 | SER Serina Therapeutics, Inc. | Sale | 3,398 | $4.24 | $14.4K | -79.2% | Form 4 ↗ |
| Nov 4, 2025 | SER Serina Therapeutics, Inc. | Sale | 3,102 | $4.40 | $13.6K | -79.6% | Form 4 ↗ |
| Oct 28, 2025 | SER Serina Therapeutics, Inc. | Sale | 5,551 | $4.96 | $27.5K | -82.5% | Form 4 ↗ |
| Oct 27, 2025 | SER Serina Therapeutics, Inc. | Sale | 949 | $5.19 | $4,925 | -82.7% | Form 4 ↗ |
| Oct 20, 2025 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $4.97 | $32.3K | -83.7% | Form 4 ↗ |
| Oct 13, 2025 | SER Serina Therapeutics, Inc. | Sale | 4,326 | $5.20 | $22.5K | -86.0% | Form 4 ↗ |
| Aug 26, 2025 | SER Serina Therapeutics, Inc. | Sale | 45,632 | $7.01 | $319.9K | -91.6% | Form 4 ↗ |
| Aug 25, 2025 | SER Serina Therapeutics, Inc. | Sale | 2,042 | $5.65 | $11.5K | -92.8% | Form 4 ↗ |
| Aug 20, 2025 | SER Serina Therapeutics, Inc. | Sale | 2,077 | $5.10 | $10.6K | -91.5% | Form 4 ↗ |
| Aug 18, 2025 | SER Serina Therapeutics, Inc. | Sale | 2,227 | $5.25 | $11.7K | -90.7% | Form 4 ↗ |
| Aug 12, 2025 | SER Serina Therapeutics, Inc. | Sale | 5,500 | $5.25 | $28.9K | -91.9% | Form 4 ↗ |
| Aug 4, 2025 | SER Serina Therapeutics, Inc. | Sale | 5,500 | $5.17 | $28.4K | -92.4% | Form 4 ↗ |
| Jul 29, 2025 | SER Serina Therapeutics, Inc. | Sale | 4,196 | $6.50 | $27.3K | -95.4% | Form 4 ↗ |
| Jul 28, 2025 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $5.89 | $38.3K | -94.1% | Form 4 ↗ |
| Jul 21, 2025 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $5.34 | $34.7K | -94.0% | Form 4 ↗ |
| Jul 14, 2025 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $5.01 | $32.6K | -93.7% | Form 4 ↗ |
| Jul 7, 2025 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $5.67 | $36.9K | -96.5% | Form 4 ↗ |
| Jun 30, 2025 | SER Serina Therapeutics, Inc. | Sale | 6,500 | $5.78 | $37.6K | -99.5% | Form 4 ↗ |
Each row links to its Form 4. Since trade compares the stock’s move from the close on the trade date (or the next trading day) to its latest close with the S&P 500 over the same days, adjusted for splits and excluding dividends. It describes the stock, not what the trader made: we don’t know their purchase price, position size or later sales. A dash means the trade isn’t matched to a listed stock, or there is no closing price after it yet.
When several people report on the same filing, we list it under the first one named, so trades by someone usually listed second may be missing here. Information, not investment advice: see the disclaimer.